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Introduction
The ovarian hyperstimulation syndrome (OHSS) is an
iatrogenic complication of ovulation induction therapy
[1]. It is a self-limited disorder that usually resolves
spontaneously within several days but may persist for
longer, particularly in conceptive cycles [2]. In its most
severe form, OHSS consists of massive ovarian
enlargement and the formation of multiple ovarian
cysts, fluid shifts resulting in extravascular fluid accu-
mulation and intravascular volume depletion, renal
failure, hypovolemic shock and, in some cases, death
[3]. The hallmark of OHSS is an increase in capillary
permeability resulting in a fluid shift from the intra-
vascular space to the third space compartment [4].
The risk factors for developing OHSS include young age,
polycystic ovary syndrome (PCOS), higher doses of
exogenous gonadotropins, very high serum estradiol
levels, a multitude of follicles, “necklace sign”, and the
possibility of ensuing pregnancy [5]. Onset of symptoms
typically occurs soon after ovulation (in superovulation
cycles) or after oocyte retrieval in assisted reproduction
therapy cycles, but it may be delayed [2]. Conception
always exacerbates the symptoms. Herein, we report
an interesting case of severe OHSS in a patient who
underwent controlled ovarian hyperstimulation (COH)
and oocyte retrieval. All her embryos were cryopreserved
and there was no embryo transfer in this cycle. However,
pregnancy was noted subsequent to this conservative
procedure.
Case Report
A 27-year-old nulligravid woman was receiving infertility
treatment at National Taiwan University Hospital. Com-
SUMMARY
Objective: We report a patient with late onset of severe ovarian hyperstimulation syndrome (OHSS) combined
with pregnancy subsequent to in vitro fertilization (IVF) cycles without embryo transfer, which is extremely rare.
Case Report: This case of severe OHSS was in a 27-year-old woman who underwent controlled ovarian
hyperstimulation (COH), oocyte collection, and IVF. All embryos were cryopreserved to prevent possible OHSS
due to an extremely high level of estradiol (6,357 pg/mL). No embryo was transferred in this cycle. However,
she was admitted 7 days after oocyte retrieval because of massive ascites and enlarged ovaries. Pregnancy was
diagnosed by serum `-human chorionic gonadotropin (51 mIU/mL) 4 days later. Fetal heartbeat was
demonstrated by ultrasound examination during follow-up.
Conclusion: Prompt recognition of pregnancy and proper medical intervention should be given to patients
with late-onset OHSS, even if no embryo was transferred in the fresh cycle. We suggest that more preventive
procedures for OHSS may be necessary for patients undergoing COH and receiving no embryo transfer, such
as oocyte donors and patients with polycystic ovary syndrome. [Taiwanese J Obstet Gynecol 2005;44(1):83–86]
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plete history and physical evaluation were consistent
with PCOS. Her menses had been irregular since
menarche at age 13. She had been married for more
than 1 year but, despite no contraception, she did not
conceive. She came to our clinic for help and under-
went ovulation induction initially. Poor response to
clomiphene citrate was noted in the first two cycles of
ovulation induction.
Intrauterine insemination was planned to help her
conceive. The cycle started on September 21, 2003. She
received clomiphene 50 mg daily for 5 days (menstrual
cycle days 4–8) and 75 IU human menopausal gonad-
otropin (hMG; Pergonal, Serono, Aubonne, Italy) at an
interval of 2 days (days 4, 6, and 8). Exaggerated
response to clomiphene citrate plus gonadotropins
was demonstrated by serial serum estradiol levels and
ultrasound examination. In order to prevent OHSS,
oocyte collection, in vitro fertilization (IVF), and
embryo freezing were suggested. Cycle cancellation
was suggested as an alternative. The patient and her
husband chose to undergo oocyte collection. The
medication was changed to 50 IU follicle-stimulating
hormone (FSH; Puregon, Organon, Oss, Netherlands)
daily on days 10 and 12–18. An extremely high
serum estrogen level (3,313 pg/mL) was noted on day
18 (October 8). Gonadotropins were coasted (i.e.
injection of human chorionic gonadotropin, hCG,
was postponed and gonadotropin administration
was withdrawn until the serum estradiol concentration
dropped below a threshold) over the following 2
days (days 19 and 20). hCG 5,000 IU was administered
on day 21 (October 11). Transvaginal ultrasound
showed 34 follicles with a diameter of more than 10 mm
and the serum estradiol level was 6,357 pg/mL.
Transvaginal oocyte retrieval on October 13, 2003, was
uneventful and 28 mature oocytes were obtained.
Twenty-three embryos were cryopreserved. To prevent
OHSS, prophylactic 25% human serum albumin (50 g)
was administered intravenously at the time of oocyte
retrieval.
The patient complained of abdominal pain and
distension, together with nausea and vomiting, 7 days
subsequent to oocyte retrieval. Her blood pressure was
110/70 mmHg and her pulse rate was 118 beats/min.
Her body weight on the day of admission was 54.9 kg.
Her abdomen was markedly distended and tender and
ultrasound revealed obvious ascites and bilateral
enlarged ovaries with multiple cysts. The red blood cell
count was 5.48 = 106/+L, hematocrit was 45%, and
white cell count was 2.48 = 104/+L, demonstrating
hemoconcentration. Renal function and liver function
tests were within normal limits. A serum estradiol level
of 9,421 pg/mL and a `-hCG level of 38 mIU/mL were
also noted. The symptoms did not subside, contrary to
our expectations.
After admission, the patient received intravenous
(IV) fluid supplement in an effort to maintain her blood
volume and to improve her urine output. Despite
vigorous therapy, the amount of ascites gradually
increased. She gained an additional 7 kg body weight
within 4 days and she became more oliguric. On the
fourth day of admission, paracentesis was carried out
under ultrasound guidance to relieve her symptoms.
This was repeated on following days. Her symptoms
gradually improved and the hematocrit decreased to
34%. The ascites gradually subsided and she was
discharged on the 15th day after admission.
Elevated `-hCG was also noted during the admis-
sion period. The day before her discharge, serum ` -hCG
was 962 mIU/mL and pregnancy was diagnosed. She
continued follow-up at our outpatient department.
One intrauterine gestational sac with a fetal heartbeat
was demonstrated by ultrasound examination on
November 18, 2003. The crown–rump length was 6.5
mm at that time. The gestational age was compatible
with the seventh gestational week.
Discussion
OHSS is a relatively common and potentially life-
threatening complication in women who undergo COH
with gonadotropins. Previous studies have reported an
incidence of severe OHSS of 1% in patients undergoing
IVF, but the incidence might be even higher because of
the tendency to under-report [6]. This patient clearly
presented with severe OHSS with signs of hemocon-
centration, oliguria, and tense ascites. Her condition
was treated successfully using IV-fluid therapy with
plasma-extender infusion and paracentesis [7].
It has been generally assumed that certain risk fac-
tors can help identify women at high risk for OHSS.
This patient showed several risk factors, including
young age, evidence of PCOS, a very high level of
serum estradiol, and a multitude of follicles. PCOS is
the major predisposing factor for OHSS. In one study,
63% of patients with severe OHSS had ultrasonically
diagnosed PCOS [8].
Asch et al report that 80% of patients with serum
estradiol levels higher than 6,000 pg/mL on the day of
hCG administration and more than 30 oocytes collected
will develop severe OHSS [5]. Shoham et al define
patients at risk for severe OHSS as those with a serum
estradiol level higher than 1,906 pg/mL on the day of
hCG administration and multiple follicular development
[9]. Chen et al examined the discriminating ability of
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estradiol concentration and oocyte number [10]. They
suggested that serum estradiol levels above 3,600
pg/mL on the day of hCG administration and/or more
than 20 oocytes retrieved are the best predictors of
severe OHSS. This patient had a very high serum es-
tradiol  level (6,357 pg/mL) and numerous follicles
during COH and was at high risk for OHSS.
To prevent the development of OHSS, several
approaches have been suggested that avoid the
deleterious effects of exaggerated ovarian response
during ovarian stimulation, such as coasting [11],
decreasing the amount of exogenous hCG [12], using
gonadotropin-releasing hormone (GnRH) agonists to
trigger ovulation [13], aspirating oocytes after ovula-
tion induction but withholding embryo transfer [14],
and canceling the cycle by aspirating follicular con-
tents prior to hCG administration [15]. This patient
had coasting during COH, half-dose hCG, and cryopre-
servation of all embryos. Canceling of this cycle was
also suggested initially as an alternative, but the
patient and her family chose to undergo COH and
embryo cryopreservation. Severe OHSS developed
despite these preventive procedures.
The rate of conception in severe OHSS is particular-
ly high [16,17]. Multiple gestations also happen more
frequently among OHSS patients, and these women
have a more prolonged and severe course [17]. Severe
OHSS without documented pregnancy always has a
milder and shorter course [17]. Although pregnancy
is an important risk factor, the symptoms of OHSS al-
ways develop before pregnancy can be documented.
Pregnancy, therefore, is of little predictive value in this
syndrome [9]. If OHSS occurs with a more prolonged
and severe course, pregnancy should be suspected even
though conception is not possible.
Halme et al reported a case of severe OHSS in a
healthy oocyte donor who was not sexually active and
donated all her oocytes to a recipient couple [18].
Except for young age, the patient had none of the risk
factors for OHSS. Since all her oocytes were collected in
that cycle, little chance of conception existed to aggra-
vate OHSS. The possible explanation for oocyte do-
nors developing OHSS may be the marked increase in
serum estradiol concentration, numerous oocytes re-
trieved, or exogenous hCG administration.
In this case, the patient underwent oocyte retrieval
and all her embryos were cryopreserved. Her condition
was similar to an oocyte donor. There was little chance
that she would conceive to aggravate the OHSS. In
addition, it is puzzling because the patient denied
intercourse with her husband during the 7 days before
and after oocyte collection. The most common estima-
tion of the lifespan of human sperm is 48–72 hours [19].
France et al demonstrated that the extreme inter-
vals that have achieved pregnancy after a single act of
coitus are 6 days prior to and 3 days after ovulation
[20]. Most pregnancies occur when coitus takes place
within the 3-day interval just prior to ovulation [21]. If
this patient’s statement is true, then the lifespan of her
husband’s sperm is more than 7 days, but this is beyond
our knowledge.
We conclude that prompt recognition of pregnancy
and proper medical intervention should be given in
patients with late onset of OHSS, even in patients who
have little chance of conception. We suggest that more
preventive procedures for OHSS may be necessary for
patients undergoing COH without embryo transfer,
such as oocyte donors and patients with PCOS.
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